Australia markets closed

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.54+0.11 (+1.17%)
At close: 04:00PM EDT
9.54 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 517.83M
Enterprise value 243.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.90
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.27

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-23.68%
S&P500 52-week change 326.49%
52-week high 316.90
52-week low 34.26
50-day moving average 311.67
200-day moving average 39.04

Share statistics

Avg vol (3-month) 31.01M
Avg vol (10-day) 3488.57k
Shares outstanding 554.91M
Implied shares outstanding 656.19M
Float 831.3M
% held by insiders 10.49%
% held by institutions 1105.22%
Shares short (30 Apr 2024) 44.58M
Short ratio (30 Apr 2024) 45.46
Short % of float (30 Apr 2024) 48.67%
Short % of shares outstanding (30 Apr 2024) 48.35%
Shares short (prior month 28 Mar 2024) 45.06M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Dec 2018
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 320 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-16.43%
Return on equity (ttm)-28.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-81.63M
Diluted EPS (ttm)-2.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)369.91M
Total cash per share (mrq)6.74
Total debt (mrq)168k
Total debt/equity (mrq)0.05%
Current ratio (mrq)33.83
Book value per share (mrq)4.96

Cash flow statement

Operating cash flow (ttm)-74.29M
Levered free cash flow (ttm)-38.91M